Zobrazeno 1 - 10
of 3 573
pro vyhledávání: '"Insulinotropic"'
Publikováno v:
Clinical and Molecular Hepatology, Vol 30, Iss 4, Pp 649-652 (2024)
Externí odkaz:
https://doaj.org/article/2efde2b9a6ed4c55bf92a92667a4b6c1
Autor:
David Vogrinc, Sara Redenšek Trampuž, Tanja Blagus, Maja Trošt, Milica Gregorič Kramberger, Andreja Emeršič, Saša Čučnik, Katja Goričar, Vita Dolžan
Publikováno v:
Heliyon, Vol 10, Iss 20, Pp e39157- (2024)
Background: Alzheimer's disease (AD) and Parkinson's disease (PD) are the most common neurodegenerative diseases. Their treatment options are rather limited, and no neuroprotective or disease-modifying treatments are available. Anti-diabetic drugs, s
Externí odkaz:
https://doaj.org/article/281d39e356af4525ac6543a3111774c3
Autor:
Tayla A. Rees, Benjamin J. Buttle, Zoe Tasma, Sung-Hyun Yang, Paul W. R. Harris, Christopher S. Walker
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Type 2 diabetes (T2D) and obesity are prevalent metabolic disorders affecting millions of individuals worldwide. A new effective therapeutic drug called tirzepatide for the treatment of obesity and T2D is a dual agonist of the GIP receptor and GLP-1
Externí odkaz:
https://doaj.org/article/0907ffccbaea49f58081214071b5e048
Autor:
Jang Won Son, Soo Lim
Publikováno v:
Endocrinology and Metabolism, Vol 39, Iss 2, Pp 206-221 (2024)
Obesity is a significant risk factor for health issues like type 2 diabetes and cardiovascular disease. It often proves resistant to traditional lifestyle interventions, prompting a need for more precise therapeutic strategies. This has led to a focu
Externí odkaz:
https://doaj.org/article/76511dc6bdf24a9cb8f6551fad04c232
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Olorunsola Israel Adeyomoye, Juliana Bunmi Adetunji, Olugbemi Temitope Olaniyan, Charles Oluwaseun Adetunji, Doris Yinka Oluwafemi
Publikováno v:
Phytomedicine Plus, Vol 4, Iss 3, Pp 100594- (2024)
Background: Diabetes mellitus remains a critical global health issue, driving the need for continual exploration of new therapeutic strategies. Ficus exasperata Vahl, renowned for its extensive ethnomedicinal use, holds promise as a potential remedy
Externí odkaz:
https://doaj.org/article/ed1fb6ac840e48d4bc7f33465cdff175
Autor:
Niya Narayanan, Jayaprakash Sahoo, Sadishkumar Kamalanathan, Haritha Sagili, Bobby Zachariah, Dukhabandhu Naik, Ayan Roy, Chandhana Merugu
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 28, Iss 1, Pp 71-79 (2024)
Introduction: The aim of this study was to compare insulin sensitivity, islet cell function, and incretin axes in pregnant subjects with GDM and normal healthy controls. Methods: Pregnant women at 24 to 28 weeks of gestation were subjected to a 75 g
Externí odkaz:
https://doaj.org/article/3b55320154a44a1e831cef8f5eb2d2c1
Autor:
Sok-Ja Janket, Miyo K. Chatanaka, Dorsa Sohaei, Faleh Tamimi, Jukka H. Meurman, Eleftherios P. Diamandis
Publikováno v:
Cells, Vol 13, Iss 22, p 1842 (2024)
Recent clinical trials using synthetic incretin hormones, glucagon-like peptide 1 (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists have demonstrated that these treatments ameliorated many complications related to obes
Externí odkaz:
https://doaj.org/article/bd7dac0cdd4546f0883b2438aa453a16
Publikováno v:
Obesity Science & Practice, Vol 10, Iss 3, Pp n/a-n/a (2024)
Abstract Background Anti‐obesity medications (AOMs) have historically had limited weight‐loss efficacy. However, newer glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA)–based therapies seem to be more effective, including dual agonists
Externí odkaz:
https://doaj.org/article/14e2bc0e80c5425c99e6b0c9950d24c0